« Wednesday’s biggest gaining and declining stocks - MarketWatch
Valeant Pharmaceuticals’ Retigabine Accepted For FDA Review - Wall Street Journal »

Valeant: Regulators review retigabine applications - BusinessWeek

Published by Google Inc. December 30th, 2009 in Google FDA News, Regulatory Affairs

Search